Glucotrack announces reverse stock split shareholder approved action meets nasdaq panel hearing listing requirements

1-for-60 reverse stock split to become effective as of the opening of trading on june 16, 2025 rutherford, nj, june 12, 2025 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will effect a 1-for-60 reverse stock split (the “reverse stock split”) of its issued and outstanding common stock par value $0.001 per share (the “common stock”), effective with the opening of trading on monday, june 16, 2025. glucotrack's common stock will continue to trade on the nasdaq capital market (“nasdaq”) under the symbol “gctk”.
GCTK Ratings Summary
GCTK Quant Ranking